Literature DB >> 1710357

Hybridization and dissociation rates of phosphodiester or modified oligodeoxynucleotides with RNA at near-physiological conditions.

S Young1, R W Wagner.   

Abstract

We have used RNase H to study both the rates of oligonucleotide hybridization and dissociation at near-physiological conditions. We have studied the Effects of oligonucleotide length, mismatch, and chemical modifications on oligonucleotide association and dissociation with RNA. Dissociation results were compared with standard thermal melting curves to compare relative stabilities evaluated by the two techniques. Although generally the two techniques correlate for the compounds evaluated, we found several instances where the thermal melting curves failed to reflect the relative stability of different oligonucleotides at 37 degrees C using near-physiological conditions. This study suggests that direct measurement of hybridization and dissociation of an oligomer with RNA more accurately assesses the complicated kinetic scheme at 37 degrees C using near-physiological conditions than thermal melting curves would predict.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1710357      PMCID: PMC329458          DOI: 10.1093/nar/19.9.2463

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  33 in total

1.  Deoxynucleotide-containing oligoribonucleotide duplexes: stability and susceptibility to RNase V1 and RNase H.

Authors:  J R Wyatt; G T Walker
Journal:  Nucleic Acids Res       Date:  1989-10-11       Impact factor: 16.971

2.  RNase H cleavage of RNA hybridized to oligonucleotides containing methylphosphonate, phosphorothioate and phosphodiester bonds.

Authors:  P J Furdon; Z Dominski; R Kole
Journal:  Nucleic Acids Res       Date:  1989-11-25       Impact factor: 16.971

3.  Oligodeoxynucleotide analogs with 5'-linked anthraquinone.

Authors:  K Mori; C Subasinghe; J S Cohen
Journal:  FEBS Lett       Date:  1989-06-05       Impact factor: 4.124

Review 4.  An approach to chemotherapy based on base sequence information and nucleic acid chemistry. Matagen (masking tape for gene expression).

Authors:  P O Ts'o; P S Miller; L Aurelian; A Murakami; C Agris; K R Blake; S B Lin; B L Lee; C C Smith
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

5.  Role of RNase H in hybrid-arrested translation by antisense oligonucleotides.

Authors:  R Y Walder; J A Walder
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

6.  Specific antiviral activity of a poly(L-lysine)-conjugated oligodeoxyribonucleotide sequence complementary to vesicular stomatitis virus N protein mRNA initiation site.

Authors:  M Lemaitre; B Bayard; B Lebleu
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

7.  Co-operative non-enzymic base recognition. 3. Kinetics of the helix-coil transition of the oligoribouridylic--oligoriboadenylic acid system and of oligoriboadenylic acid alone at acidic pH.

Authors:  D Pörschke; M Eigen
Journal:  J Mol Biol       Date:  1971-12-14       Impact factor: 5.469

8.  Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates.

Authors:  J F Milligan; D R Groebe; G W Witherell; O C Uhlenbeck
Journal:  Nucleic Acids Res       Date:  1987-11-11       Impact factor: 16.971

9.  Comparative inhibition of chloramphenicol acetyltransferase gene expression by antisense oligonucleotide analogues having alkyl phosphotriester, methylphosphonate and phosphorothioate linkages.

Authors:  C J Marcus-Sekura; A M Woerner; K Shinozuka; G Zon; G V Quinnan
Journal:  Nucleic Acids Res       Date:  1987-07-24       Impact factor: 16.971

10.  Control of replication of plasmid R1: formation of an initial transient complex is rate-limiting for antisense RNA--target RNA pairing.

Authors:  C Persson; E G Wagner; K Nordström
Journal:  EMBO J       Date:  1990-11       Impact factor: 11.598

View more
  9 in total

1.  Small, efficient hammerhead ribozymes.

Authors:  M J McCall; P Hendry; A A Mir; J Conaty; G Brown; T J Lockett
Journal:  Mol Biotechnol       Date:  2000-01       Impact factor: 2.695

2.  Specificity of antisense oligonucleotides in vivo.

Authors:  T M Woolf; D A Melton; C G Jennings
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

3.  RNA stem-loop enhanced expression of previously non-expressible genes.

Authors:  Michael Paulus; Martin Haslbeck; Manfred Watzele
Journal:  Nucleic Acids Res       Date:  2004-05-26       Impact factor: 16.971

4.  Optical absorption assay for strand-exchange reactions in unlabeled nucleic acids.

Authors:  Besik I Kankia
Journal:  Nucleic Acids Res       Date:  2004-11-01       Impact factor: 16.971

5.  A novel method to stabilise antisense oligonucleotides against exonuclease degradation.

Authors:  I M Khan; J M Coulson
Journal:  Nucleic Acids Res       Date:  1993-06-25       Impact factor: 16.971

6.  A high throughput method to investigate oligodeoxyribonucleotide hybridization kinetics and thermodynamics.

Authors:  A Mazumder; M Majlessi; M M Becker
Journal:  Nucleic Acids Res       Date:  1998-04-15       Impact factor: 16.971

7.  Inhibition of dengue virus by novel, modified antisense oligonucleotides.

Authors:  K Raviprakash; K Liu; M Matteucci; R Wagner; R Riffenburgh; M Carl
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

8.  Design, biochemical, biophysical and biological properties of cooperative antisense oligonucleotides.

Authors:  E R Kandimalla; A Manning; C Lathan; R A Byrn; S Agrawal
Journal:  Nucleic Acids Res       Date:  1995-09-11       Impact factor: 16.971

9.  Oligodeoxyribonucleotide probe accessibility on a three-dimensional DNA microarray surface and the effect of hybridization time on the accuracy of expression ratios.

Authors:  David R Dorris; Allen Nguyen; Linn Gieser; Randall Lockner; Anna Lublinsky; Marcus Patterson; Edward Touma; Timothy J Sendera; Robert Elghanian; Abhijit Mazumder
Journal:  BMC Biotechnol       Date:  2003-06-11       Impact factor: 2.563

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.